"Any patients with a history of peripheral arterial disease or any kind of vascular disease should discuss that with their doctor," Dr
Intermittent fasting and bone health: a bone of contention
Semaglutide binding was determined using surface plasmon resonance biosensor technology (Biacore T100 Instrument, GE Healthcare Bio-Sciences AB, Ume, Sweden), in which semaglutide was immobilized at the surface and diluted plasma, collected prior to dosing, was passed over the sensor chip
If you miss a dose or are unsure when to take your medication, Rafael Olartecoechea and his team are always available to provide guidance
In the latest episode of the Beyond Journal Club podcast from @COREIMpodcast and NEJM Group, the hosts unpack the evolving language of steatotic liver disease and discuss two major trials: MAESTRO-NASH studying resmetirom, the first FDA-approved liver-directed therapy for MASH, and ESSENCE, evaluating semaglutide in biopsy-confirmed disease